Open AccessConservative therapy with a gonadotropin‐releasing hormone agonist for a uterine arteriovenous malformation in a patient with congenital heart disease
Author(s) -
Katano Kinue,
Takeda Yutaka,
SugiuraOgasawara Mayumi
Publication year - 2015
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.233
Subject(s) - medicine , gonadotropin releasing hormone agonist , heart disease , arteriovenous malformation , agonist , disease , gonadotropin releasing hormone , surgery , gynecology , cardiology , hormone , luteinizing hormone , receptor
Key Clinical Message Uterine arteriovenous malformation ( AVM ) is rare but it can cause life‐threatening genital bleeding. Conservative therapy with Gn RH a can be a useful option for treating a uterine AVM presenting with a congenital heart disease shunt in hemodynamically stable patients.